KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Moderna (MRNA) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Moderna (MRNA) over the last 10 years, with Q3 2025 value amounting to $390.0 million.

  • Moderna's Shares Outstanding (Weighted Average) rose 129.87% to $390.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $390.0 million, marking a year-over-year increase of 129.87%. This contributed to the annual value of $384.0 million for FY2024, which is 52.36% up from last year.
  • As of Q3 2025, Moderna's Shares Outstanding (Weighted Average) stood at $390.0 million, which was up 129.87% from $388.0 million recorded in Q2 2025.
  • Over the past 5 years, Moderna's Shares Outstanding (Weighted Average) peaked at $404.0 million during Q3 2021, and registered a low of $382.0 million during Q3 2023.
  • Over the past 5 years, Moderna's median Shares Outstanding (Weighted Average) value was $388.0 million (recorded in 2025), while the average stood at $391.2 million.
  • Per our database at Business Quant, Moderna's Shares Outstanding (Weighted Average) skyrocketed by 1331.44% in 2021 and then crashed by 401.0% in 2023.
  • Moderna's Shares Outstanding (Weighted Average) (Quarter) stood at $403.0 million in 2021, then dropped by 2.23% to $394.0 million in 2022, then decreased by 3.05% to $382.0 million in 2023, then rose by 0.52% to $384.0 million in 2024, then rose by 1.56% to $390.0 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $390.0 million in Q3 2025, compared to $388.0 million in Q2 2025 and $386.0 million in Q1 2025.